News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Twilio posted quarterly results that beat forecasts and raised its growth outlook.
  • Company introduced a new AI conversation layer.
  • Upgraded outlook increases the probability of upward earnings estimate revisions.
  • Unit economics are improving across the business.
  • Twilio is producing material free cash flow.
  • Market note recommends a directional long swing trade over the next 45 trading days.

Latest Articles

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

Lifeward Ltd. has launched a six-month pilot program with Ottobock Care to increase patient access to the ReWalk® 7 Personal Exoskeleton across the U.S. The partnership leverages Ottobock Care's clinical expertise and nationwide clinic network to enhance patient evaluation, training, and follow-up, aiming to scale ReWalk's commercial reach and acce…

ImageneBio Reports Second Quarter 2026 Financial Results

ImageneBio Reports Second Quarter 2026 Financial Results

ImageneBio announced its financial results for Q2 2026 alongside clinical progress for its lead candidate, olevaprubart, a differentiated anti-OX40 monoclonal antibody targeting immunological diseases such as atopic dermatitis and alopecia areata. The Phase 2b trial in moderate-to-severe atopic dermatitis is advancing as planned with an amended pro…

High Roller Technologies Schedules Conference Call to Provide a Business Update and Discuss Second Quarter 2026 Financial Results

High Roller Technologies Schedules Conference Call to Provide a Business Update and Discuss Second Quarter 2026 Financial Results

High Roller Technologies, a publicly traded company on NYSE (ticker: ROLR) specializing in online gaming and prediction markets, announced a conference call on August 11, 2026, to discuss its Q2 financial results and provide a business update. Management will also highlight strategic initiatives, including a planned launch of prediction markets. Th…

Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis

Damora Therapeutics announced the initiation of the global Phase 1/1b CLARITY-101 clinical trial to evaluate DMR-001, a novel monoclonal antibody designed to target mutant calreticulin (mutCALR) in patients with essential thrombocythemia and myelofibrosis. Preclinical data showed DMR-001 has significantly higher binding potency and longer half-life…

Global Indemnity Group, LLC Reports Financial Results for the three and six months ended June 30, 2026

Global Indemnity Group, LLC Reports Financial Results for the three and six months ended June 30, 2026

Global Indemnity Group, LLC reported strong financial results for the three and six months ended June 30, 2026. The company posted an 8% increase in quarterly net income to $11.1 million, driven by a favorable loss ratio of 53.8%. Belmont Core segment gross written premiums grew by 7% in Q2. For the six months, net income surged to $15.3 million fr…

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Ascentage Pharma, a global biopharmaceutical company focused on cancer therapies, will release its unaudited six-month interim results for 2026 on August 19, 2026. The company will host investor webcasts in English and Mandarin, providing updates on its drug pipeline, ongoing Phase III clinical trials, and partnerships with key industry players. Th…

Elanco Shares Leap After Q2 Results Beat Expectations, Guidance Raised

Elanco Shares Leap After Q2 Results Beat Expectations, Guidance Raised

Elanco Animal Health rallied in pre-market trading after reporting second-quarter 2026 results that outpaced analyst expectations across key metrics and prompted management to lift its full-year outlook. The company posted adjusted EPS of $0.34 versus consensus of $0.27 and revenue of $1.37 billion against estimates of $1.31 billion, with robust co…

Citadel’s Big Funds Record July Gains as AI-Fueled Tech Selloff Hits Peers

Citadel’s Big Funds Record July Gains as AI-Fueled Tech Selloff Hits Peers

Citadel’s three large funds delivered solid gains in July even as a sector-wide technology selloff linked to concerns about AI spending inflicted losses on many hedge funds. The firm’s Wellington fund rose 6% in July (up 12% year-to-date), its tactical trading arm gained 11% in July (up 27% YTD) and its stock-focused equities fund increased 14.2% f…

AMD Posts Blowout Q2; Rally Meets a Rich Valuation and Fresh Questions

AMD Posts Blowout Q2; Rally Meets a Rich Valuation and Fresh Questions

AMD reported a blockbuster second quarter with revenue of $11.5 billion and a doubling of its data-center business, yet the stock fell sharply after earnings as investors weighed valuation, a potential Anthropic equity commitment, and divergent analyst targets. The business momentum is clear, but market pricing and execution risks are the core issu…

New York Times Shares Slide After Q2 Results and Softer Subscription Outlook

New York Times Shares Slide After Q2 Results and Softer Subscription Outlook

New York Times Co. stock fell 8.8% in pre-open trading after the company reported second-quarter 2026 results and issued a tempered forecast for subscription revenue in Q3. While adjusted EPS and total revenue topped estimates, a smaller-than-expected gain in digital-only subscribers and guidance for slower subscription revenue growth prompted inve…

BEP Trade Idea: Buy the AI-Driven Repricing of Flexible Renewables

BEP Trade Idea: Buy the AI-Driven Repricing of Flexible Renewables

Brookfield Renewable (BEP) is a play on rising AI-driven electricity demand and the shift to flexible, dispatchable renewable assets. The company’s growing battery/storage footprint, contracts with hyperscalers, and a forthcoming corporate simplification make a mid-term long trade attractive at current levels. Entry at $33.05, stop at $31.50, targe…

Bloomin' Brands Jumps After Q2 Beat and Upgraded Guidance

Bloomin' Brands Jumps After Q2 Beat and Upgraded Guidance

Bloomin' Brands rallied sharply in pre-market trading after reporting second-quarter adjusted EPS and revenue that topped analyst estimates, alongside broad-based U.S. comparable sales gains across its four restaurant brands and an increase to full-year adjusted earnings guidance. The results prompted rapid investor revaluation, sending the stock w…

Hemisphere Energy: A Tactical Long with a Cooler Oil Base Case

Hemisphere Energy: A Tactical Long with a Cooler Oil Base Case

Hemisphere Energy (HMENF) looks like a tradable long from current levels. The stock is trading below its short- and medium-term moving averages, RSI sits near 41, and short activity is substantial — all of which set up a bounce if oil stabilizes. I’m recommending a mid-term swing trade with clear entry, stop and target, while recognizing macro oil …

Insulet Shares Plunge After Q2 Beat, Company Narrows Revenue Growth Target

Insulet Shares Plunge After Q2 Beat, Company Narrows Revenue Growth Target

Insulet Corporation reported second-quarter 2026 results that beat estimates on both adjusted EPS and revenue, but the stock plunged in pre-market trading after management trimmed its full-year revenue growth forecast. While adjusted EPS and revenue exceeded expectations, the reduced revenue growth outlook, a recent analyst downgrade and an ongoing…

Shopify Pops on Strong Q2: Revenue, EPS and Cash Flow Outperform Estimates

Shopify Pops on Strong Q2: Revenue, EPS and Cash Flow Outperform Estimates

Shopify shares jumped sharply in pre-market trading after the company reported Q2 2026 results that exceeded analyst forecasts and its own guidance range. Revenue, adjusted EPS, gross merchandise volume and free cash flow all outperformed expectations, while a wave of analyst upgrades ahead of the release amplified investor enthusiasm. A supportive…

Global Payments Slides After Q2 Report and Trimmed Full-Year Guidance

Global Payments Slides After Q2 Report and Trimmed Full-Year Guidance

Global Payments shares fell in pre-market trading after the company posted an in-line Q2 adjusted EPS but reduced its full-year adjusted EPS guidance and trimmed its normalized revenue growth outlook, citing travel-volume weakness linked to the Middle East conflict as the primary headwind. The guidance cut, rather than the quarter itself, drove the…